Skip to content

ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients

Accuracy of ShuntCheck and MRI in Detection of Shunt Obstruction in Patients Receiving Shunt Patency Test

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00793416
Enrollment
0
Registered
2008-11-19
Start date
2008-11-30
Completion date
2012-08-31
Last updated
2013-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Pressure Hydrocephalus

Keywords

Normal Pressure Hydrocephalus, Valve Adjustment, Blocked Shunt in NPH patients, Diagnosis of blockage

Brief summary

The purpose of this study is to examine the role of ShuntCheck and MR Imaging in evaluating the presence or absence of Shunt Obstruction in the patients of Hydrocephalus or Idiopathic Intracranial Hypertension (IIH) undergoing radionuclide test for suspected shunt obstruction. This is an exploratory study to determine how a non-invasive device can assist in detection of presence of flow in these patients.

Detailed description

This study aims to correlate findings of ShuntCheck and MRI with the Radionuclide patency study. Patients will be enrolled if they have Hydrocephalus or IIH, present with symptoms of shunt obstruction and will need to undergo shunt patency test and an MRI along with standard of care radionuclide study. The ShuntCheck study will be conducted in a clinic, doctor's office or in an emergency room by the treating physician or by trained health care professionals. Also, patients who are found with shunt obstruction as diagnosed by Radionuclide study will undergo shunt revision and the findings of the study will be correlated with operative findings. Post Shunt replacement patients who also receive adjustable valve will be evaluated with shunt Check, before and after adjustment of valves to detect changes in flow as detected by shunt check. This is an exploratory study to determine how a non-invasive device can assist in detection of presence of flow in these patients. Approximately 20 subjects will be enrolled in a single site in this proof of concept, physician sponsored study. An approved, commercial device will be available to the site prior to start of the study.

Interventions

DEVICEShunt flow detection

Shunt flow detection based upon ShuntCheck results compared to radionuclide test results

Sponsors

Johns Hopkins University
CollaboratorOTHER
NeuroDx Development
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Adult Patients \> 35 years capable and willing to consent for their participation or consent obtained from a legal guardian. 2. Patients with an indwelling shunt and clinical assessment strongly suggestive of shunt obstruction 3. Patients are candidates for shunt patency procedures in the elective extension

Exclusion criteria

1. Patients \<35 years of age 2. Patients with symptoms attributable to valve malfunction or shunt infection 3. Patients who need urgent shunt replacement and therefore cannot wait for the SHUNTCHECK evaluation of shunt patency. 4. Patients with edema or wound of skin overlying the shunt tissue. 5. Patients not capable or not willing to consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Exploratory Evaluation of the Utility of ShuntCheck in detection of ShuntFlow in patients admitted with potential shunt obstructionPre and post shunt revision surgery

Secondary

MeasureTime frame
To assess any adverse events that arise from conducting ShuntCheck test To assess the cost effectiveness of ShuntCheck screening upon completion of the studyPre and post shunt revision surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026